Benzinga

JULY 5, 2023

According to Emergen Research, the global depression treatment market size was $12.1 is also pleased to announce the formation of Lucy Discoveries Holdings, a new entity that will serve as a platform for the continued advancement of psychedelic medicine research and development. . "We billion in 2019 and is expected to reach $16.1

Marketability 40

Marketability 40

Benzinga

MARCH 22, 2023

Secondly, the addition of this premier marketing agency showcases Irwin's capacity to attract top-tier talent as it aims to establish the world's largest network of psychedelic mental health clinics. We aim to foster greater collaboration within this emerging sector among local market providers.

EBITDA 40

EBITDA Marketability 40

Benzinga

MARCH 21, 2023

Secondly, the addition of this premier marketing agency showcases Irwin's capacity to attract top-tier talent as it aims to establish the world's largest network of psychedelic mental health clinics. We aim to foster greater collaboration within this emerging sector among local market providers.

EBITDA 40

EBITDA Marketability 40

Benzinga

FEBRUARY 21, 2023

First, the acquisition is expected to be immediately accretive increasing the company's annualized EBITDA by double digits and second, the addition of this clinic further demonstrates Irwin's ability to attract profitable clinics as part of its goal to establishing the world's largest network of psychedelic mental health clinics.

EBITDA 40

EBITDA Marketability 40

Benzinga

FEBRUARY 17, 2023

First, the acquisition is expected to be immediately accretive increasing the company's annualized EBITDA by double digits and second, the addition of this clinic further demonstrates Irwin's ability to attract profitable clinics as part of its goal to establishing the world's largest network of psychedelic mental health clinics.

EBITDA 40

EBITDA Marketability 40

Benzinga

NOVEMBER 9, 2022

This will be the first facility in Washington for Irwin Naturals Emergence, a fast-growing national chain of psychedelic mental-health clinics. We've sought to move to the front of this market by moving fast while also being incredibly selective.

Marketability 40

Marketability 40

Benzinga

DECEMBER 12, 2022

The sale of Mindleap is a significant step towards refocusing the Company's resources on its primary strategy of discovering and developing innovative pharmaceutical psychedelic substances to meet the unmet needs of millions of patients worldwide. "We Transaction Details. per Unit.

Technology 40

Technology Marketability 40

Benzinga

MAY 19, 2022

OTC: TPIA ) (the "Company"), a biopharma company focused on research, technology, and the development of medical psychedelics, announced today an update on the previously announced merger with Ei.Ventures Inc. ("Ei"). Upon the closing of the transaction, PSLY.com will have a market value of approximately $383 million. MERGER UPDATE.

Technology 52

Technology Marketability 52

Benzinga

APRIL 25, 2024

OTCQB: TRYPF ), a Canadian biotech leader in psychedelics , has officially received approval from Exopharm Limited shareholders for their strategic merger, paving the way for a new entity, Tryptamine Therapeutics Limited. Tryp Therapeutics Inc.

Marketability 52

Marketability 52

Benzinga

AUGUST 17, 2023

Cannabis and psychedelics consumption continued on a long-term upward trajectory to reach all-time highs in 2022, according to a Monitoring the Future (MTF) study. Although teenage marijuana use showed a year-over-year decline per last summer’s survey.

Marketability 98

Marketability 98

Benzinga

OCTOBER 18, 2023

Short-acting psychedelics biotech Small Pharma Inc. See Also: Billionaire Steve Cohen Buys 19M Shares Of Cybin Stock For Psychedelics R&D, Blake Mycoskie $100M Pledge With this approval and. NYSE: CYBN ) is set to acquire all the former’s issued and outstanding securities in an all-share transaction.

Marketability 80

Marketability 80

Benzinga

DECEMBER 11, 2023

Canadian psychedelics biotech Tryp Therapeutics Inc. has entered into an agreement with Australian publicly-trading drug vehicle developer Exopharm Ltd. for the acquisition of 100% of Tryp’s issued and outstanding common shares. The arm’s length transaction, dated Dec.

Marketability 59

Marketability 59

Benzinga

OCTOBER 20, 2023

OTCQB: DMTTF ), the short-acting psychedelics biotech about to be purchased by Cybin Inc. Small Pharma Inc. NYSE: CYBN ), published its interim financial results for Q2 ended August 31, 2023. Numbers showed: Cash of $5.6 (CA$7.68) CA$7.68) million by August 31, vs. $13.5 million held by Feb. 28, 2023, a 58.6% six-month burn rate.

Marketability 64

Marketability 64

Benzinga

OCTOBER 7, 2022

As of January 2023 , Canada’s 4th largest province will be the first to offer supervised treatments involving psychedelic substances such as psilocybin, MDMA, LSD, mescaline, DMT and ketamine to those among its 4.5 million population suffering from mental health disorders.

Marketability 98

Marketability 98

Benzinga

SEPTEMBER 28, 2022

According to information procured exclusively by Benzinga ahead of an official announcement , global psychedelics company Silo Wellness Inc. OTCQB: SILFF ) (CSE: SILO) (FSE: 3K7A) is acquiring Dyscovry Science Ltd. ,

Marketability 98

Marketability 98

Benzinga

OCTOBER 13, 2023

Psychedelics therapy provider Optimind Pharma Corp. an arm's length private British Columbia corporation with investments in the psychedelics industry and one of its wholly-owned subsidiaries. entered into an acquisition agreement with Wolf Acquisitions 1.0

Marketability 59

Marketability 59

Benzinga

NOVEMBER 11, 2022

Psychedelic medicine and telehealth provider TripSitter Clinic Ltd. has closed the acquisition of assets of Insight Systems PBC -aka Reconscious Medical- , a psychedelic psychotherapy company engaging in both in-clinic and online virtual care with safety, monitoring and support provided via a novel technology platform.

Technology 98

Technology Marketability 98

Benzinga

OCTOBER 6, 2022

Ontario-based producer of functional mushroom home grow kits and premium magic truffles Red Light Holland Corp. OTC Pink: TRUFF ) has acquired MiniChamp B.V. , a dutch home grow mushroom farm, through its wholly-owned subsidiary RLH Netherlands B.V.

Marketability 98

Marketability 98

Benzinga

AUGUST 16, 2022

Publicly traded psychedelics company Psycheceutical Bioscience Inc. OTC: BWVI ) is signing an exclusive purchase option with end-to-end pharma R&D company Vici Health Sciences ’ majority equity stake.

Equity 98

Equity Technology Marketability 98

Benzinga

OCTOBER 26, 2023

Psychedelic venture studio Beckley Waves has acquired ketamine-assisted therapy provider Nue Life and will continue its work by offering safe and scalable access to treatment with an emphasis on underserved areas. Co-founded by Amanda Feilding and recently raising $3.3 Co-founded by Amanda Feilding and recently raising $3.3

Marketability 52

Marketability 52

Benzinga

AUGUST 3, 2022

Founded by psychedelic pioneers Zappy Zapolin and Warren Gumpel along with mindfulness instructor Kaia Roman and president and COO Leann Taylor , KetaMD's telemedicine platform works to provide access to safe and affordable at-home ketamine treatments for those suffering from depression and related mental health conditions across the country.

Marketability 98

Marketability Technology 98

Benzinga

AUGUST 31, 2023

Canadian next-generation psychedelics developer Mindset Pharma (OTCMKTS: MSSTF) has entered into a definitive agreement by which Otsuka America Inc., Psychedelic Alpha recalls that collaboration began in January 2022 when Mindset entered into a partnership with Otsuka’s McQuade Center. arm of Otsuka Pharmaceutical Co.,

Alpha 52

Alpha Marketability 52

Benzinga

MAY 20, 2022

Two companies in the psychedelics space have signed a definitive agreement to merge. Both companies are are working on research, development and commercialziation of naturally-produced psychedelics like psilocybin mushrooms. Mycotopia Therapies Inc. OTCPink: TPIA ) and Ei.Ventures Inc. The Details.

Marketability 98

Marketability 98

Benzinga

MAY 20, 2022

Irwin Naturals (OTCQB: IWINF) (FRA:97X) has completed the acquisition of KHC Capital Group, LLC. following the April acquisition agreement with KHC Capital and related entities (Ketamine Health Centers), which owns a chain of five ketamine treatment clinics in Florida with an additional partnership contract with an affiliate clinic in Mexico.

Marketability 98

Marketability 98

Benzinga

APRIL 12, 2022

Following the transaction, the combined company will operate 13 wellness clinics and will be positioned as a leading psychedelic-assisted therapy provider in North America, leading its peer group in revenue with approximately CA$10 million in annual pro-forma revenue based on the trailing four quarters. million ($20.74

Marketability 98

Marketability 98

Benzinga

APRIL 6, 2022

The investment holding company Blackhawk Group (CSE: BLR) announced that it has entered into an all-stock purchase agreement with Blum Distributors Ltd. Blum is a mycology supplier with in-house product cultivation, distribution and sales center. The company recently signed a contract with Applied Myco to provide a white label solution.

Marketability 98

Marketability 98

Benzinga

JULY 5, 2023

Psychedelics biotech Awakn Life Sciences Corp. OTCQB: AWKNF ) sold its London subsidiary and healthcare clinic. The deal comes on the heels of a recently announced business strategy change. What Happened : The clinic’s new proprietor, a joint venture named Awakn Via Amitis Ltd. ,

Marketability 52

Marketability 52

Benzinga

SEPTEMBER 12, 2023

toward further entering the global wellness market with novel psychotropic products. At that time, the BlueSky team will market Lucy’s MINDFUL brand as well as several psychotropic products. Canadian drug development company Lucy Scientific Discovery Inc. Full story available on Benzinga.com

EBITDA 52

EBITDA Marketability 52

Benzinga

JUNE 5, 2023

Health Canada-licensed psychedelics producer Lucy Scientific Discovery (NASDAQ: LSDI ) announced it has sent a proposal to biotech business Pasithea Therapeutics Corp. NASDAQ: KTTA ) to acquire each share of its common stock.

Marketability 52

Marketability 52

Benzinga

MAY 18, 2023

See also: Psychedelic Therapies Soon Available In Australia Via Incannex Healthcare And Subsidiary The partnership will not charge. (affiliated with GMP-compliant CCrest Labs) received Health Canada’s approval to provide proprietary LaNeo MDMA capsules to a Canadian physician for patient treatment under the Special Access Program (SAP.)

Marketability 52

Marketability 52

Benzinga

AUGUST 3, 2023

(OTCQB: PLSH ) has entered into a letter of intent with Melodial Global Health (formerly Creso Pharma ) to acquire Sierra Sage Herbs , maker of the G re en Goo, Southern Butter and Good Goo natural products and Halucenex , a company researching novel psychedelic compounds.

Marketability 52

Marketability 52

Benzinga

APRIL 4, 2023

Psychotherapists at the Massachusetts General Hospital (MGH) have undergone training by lead business Fluence toward participating in Tryp Therapeutics (OTCQB: TRYPF )’ Phase 2a trial assessing psilocybin-assisted psychotherapy on adult participants with treatment-resistant Irritable Bowel Syndrome (IBS) who experience chronic abdominal pain (..)

Marketability 52

Marketability 52

Benzinga

FEBRUARY 10, 2023

Canadian biopharma psychedelics company Cube Psytech Holdings agreed to acquire Translational Life Sciences (TLS). Cube will issue about 50% of its outstanding shares, warrants and options to shareholders, directors and employees of TLS in exchange for 100% of its outstanding share capital.

Finance 52

Finance Marketability 52

Benzinga

DECEMBER 13, 2022

OTC: MYCOF ), a biotech company engineering next-gen psychedelic therapeutics, announced that it has closed the sale of all of issued and outstanding shares of its wholly-owned subsidiary, Mindleap Health Inc. Mydecine Innovations Group Inc. to PanGenomic Health Inc.,

Technology 52

Technology Marketability 52

Benzinga

MARCH 22, 2023

This acquisition empowers Irwin Naturals to broaden its presence in the burgeoning ketamine therapy market and offer a diverse array of marketing solutions to support the company's products and services. Ketamine Media is an advertising company dedicated to raising awareness about the clinical use of ketamine.

Marketability 52

Marketability 52

Benzinga

FEBRUARY 21, 2023

Irwin Naturals Inc. OTCQB: IWINF ) (CSE:IWIN) (FRA:97X) has successfully completed the acquisition of Serenity Health, LLC , a ketamine clinic in Louisville, KY. The agreement with Serenity was initially announced November 30, 2022.

EBITDA 52

EBITDA Marketability 52

Benzinga

JANUARY 27, 2023

Irwin Naturals Inc. OTCQB: IWINF ) (CSE:IWIN) (FRA:97X), has entered into a non-binding amended and restated letter of intent for a business combination with Braxia Scientific Corp. OTCPK:BRAXF) (CSE:BRAX) (FWB:4960), a medical research company providing psychiatric, innovative ketamine and psilocybin treatments for mental health disorders.

Marketability 52

Marketability 52